塞库金单抗
医学
强直性脊柱炎
单克隆抗体
脊柱炎
单克隆
内科学
临床试验
免疫学
抗体
关节炎
银屑病性关节炎
作者
Dominique Baeten,Joachim Sieper,J. Braun,Xenofon Baraliakos,Maxime Dougados,Paul Emery,Atul Deodhar,Brian Porter,Ruvie Martin,Mats Andersson,Shephard Mpofu,Hanno B. Richards
标识
DOI:10.1056/nejmoa1505066
摘要
Secukinumab is an anti–interleukin-17A monoclonal antibody that has been shown to control the symptoms of ankylosing spondylitis in a phase 2 trial. We conducted two phase 3 trials of secukinumab in patients with active ankylosing spondylitis.
科研通智能强力驱动
Strongly Powered by AbleSci AI